Hubei Ouli Pharmaceutical Co., Ltd.
-
Founded in:
2005-06-28 -
Country:
China -
Address:
No. 619, Shenxia Road, Huangshi City -
Tax NO.:
91420200773943406N -
Registered Funds:
10 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Levamisole hydrochloride |
It selectively inhibits succinate dehydrogenase in the muscles of the worm, affects the anaerobic metabolism of the worm muscles, and reduces energy production; it depolarizes the nerve muscles, causing the worm muscles to continue to contract and paralyze; its cholinergic effect helps the worm to be expelled; it may have an inhibitory effect on the microtubule structure of the worm; it has immune regulation and immune excitation functions.
More
It selectively inhibits succinate dehydrogenase in the muscles of the worm, affects the anaerobic metabolism of the worm muscles, and reduces energy production; it depolarizes the nerve muscles, causing the worm muscles to continue to contract and paralyze; its cholinergic effect helps the worm to be expelled; it may have an inhibitory effect on the microtubule structure of the worm; it has immune regulation and immune excitation functions. |
16595-80-5 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hydroxyl camptothecine |
Extract from the above information
More
Extract from the above information |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hydrotalcite |
Extract from the above information
More
Extract from the above information |
12304-65-3 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tegafur |
This product is a derivative of fluorouracil. It is activated by the liver in the body and converted into fluorouracil to exert its anti-tumor activity, interfere with DNA and RNA synthesis, and mainly acts on the S phase. It is a cell cycle-specific drug. The chemotherapy index is twice that of fluorouracil, and the toxicity is only 1/4 to 1/7 of that of fluorouracil.
More
This product is a derivative of fluorouracil. It is activated by the liver in the body and converted into fluorouracil to exert its anti-tumor activity, interfere with DNA and RNA synthesis, and mainly acts on the S phase. It is a cell cycle-specific drug. The chemotherapy index is twice that of fluorouracil, and the toxicity is only 1/4 to 1/7 of that of fluorouracil. |
17902-23-7 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diammonium glycyrrhizinate |
It has certain anti-inflammatory, liver cell membrane protection and liver function improvement effects. It can reduce the increase of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) caused by carbon tetrachloride, thioacetamide and D-aminogalactic acid, reduce the damage of D-aminogalactic acid to the liver and improve the chronic damage of immune factors to the liver.
More
It has certain anti-inflammatory, liver cell membrane protection and liver function improvement effects. It can reduce the increase of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) caused by carbon tetrachloride, thioacetamide and D-aminogalactic acid, reduce the damage of D-aminogalactic acid to the liver and improve the chronic damage of immune factors to the liver. |
79165-06-3 | 35 |